Literature DB >> 32049107

Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders.

Thirupambaram Natarajasundaram Uma Maheswari1, Malli Sureshbabu Nivedhitha2, Prathiba Ramani3.   

Abstract

Oral potentially malignant disorders (OPMD) possess significant chances of malignancy conversion. In order to develop an early diagnostic tool, the present study evaluated the expression of miRNA-21 and 31 as salivary markers. The case-control study was carried out in 36 healthy participants as controls and in 36 patients who were newly diagnosed as OPMD having four different lesions including leucoplakia, oral sub mucous fibrosis (OSMF)궱, oral lichen planus, and (OSMF)궱 with leucoplakia. The samples were also classified as non-dysplastic, or with mild, moderate, and severe dysplasia according to their histopathological reports. The salivary miRNA-21 and 31 expressions were studied using real-time PCR. The statistical analysis was carried out using SPSS version 22. Salivary miRNA-21 (p-value = 0.02) and 31 (p-value = 0.01) were significantly upregulated in severe dysplasia compared with control. Among the different lesions, leucoplakia had significant upregulation of miRNA-21 and 31. miRNA-21 can be used as a diagnostic marker with specificity of 66% and sensitivity of 69%. The area under the ROC curve was 0.820 for miRNA-21 and 0.5 for miRNA-31, which proved that miRNA-21 is a better diagnostic marker than miRNA-31 for OPMD.

Entities:  

Year:  2020        PMID: 32049107     DOI: 10.1590/1807-3107bor-2020.vol34.0002

Source DB:  PubMed          Journal:  Braz Oral Res        ISSN: 1806-8324


  7 in total

1.  Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed samples from oral potentially malignant disorders.

Authors:  Hsi-Feng Tu; Kuo-Wei Chang; Shu-Chun Lin; Wan-Wen Hung; Si-Hua Ji; Hsiao-Li Wu; Chung-Ji Liu
Journal:  J Dent Sci       Date:  2021-07-30       Impact factor: 3.719

2.  Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder.

Authors:  Hsi-Feng Tu; Li-Han Lin; Kuo-Wei Chang; Hui-Wen Cheng; Chung-Ji Liu
Journal:  J Dent Sci       Date:  2021-09-20       Impact factor: 3.719

Review 3.  Salivary Micro-RNA and Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Maria Menini; Emanuele De Giovanni; Francesco Bagnasco; Francesca Delucchi; Francesco Pera; Domenico Baldi; Paolo Pesce
Journal:  J Pers Med       Date:  2021-02-04

4.  Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma.

Authors:  Parma Kumari; Sofia A Syed; Mohsin Wahid; Muhammad A Qureshi; Rajesh Kumar
Journal:  J Taibah Univ Med Sci       Date:  2021-04-22

Review 5.  Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?

Authors:  Aditi Patel; Shanaya Patel; Parina Patel; Vivek Tanavde
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 5.738

Review 6.  Clinical Perspectives of Non-Coding RNA in Oral Inflammatory Diseases and Neuropathic Pain: A Narrative Review.

Authors:  Jelena Roganović; Nina Petrović
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

7.  The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.

Authors:  Shu-Chun Lin; Chung-Ji Liu; Si-Hua Ji; Wan-Wen Hung; Ying-Chieh Liu; Sih-Rou Chang; Hsi-Feng Tu; Kuo-Wei Chang
Journal:  Clin Oral Investig       Date:  2021-08-03       Impact factor: 3.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.